About Resinno
Resinno is a Healthcare company based in Mumbai (India) founded in 2018. It serves as a CDMO specializing in the manufacturing of active pharmaceutical ingredients. It operates on a B2B model. Its Indian entity Resinno Biotech Private Limited reported revenue of ₹45.1 Lakh. Its focus areas include Pharmaceuticals, Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Resinno serves as a cdmo specializing in the manufacturing of active pharmaceutical ingredients, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website resinnobiotech.com
- Legal Name Resinno Biotech Private Limited
- Date of Incorporation 25 Jan, 2018
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹45.1 Lakh
FY 2024 · -55% YoY
- Net Loss-₹7.7 Lakh
FY 2024 · -17% margin
- EBITDA-₹6.9 Lakh
FY 2024 · -15% margin
Associated legal entities of Resinno
Resinno is associated with 2 registered companies on The Company Check; the primary company is Resinno Biotech Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Resinno Biotech Private Limited CIN U85320MH2018PTC304666 | Active | 25 Jan 2018 | Navi Mumbai, Maharashtra | ₹0.5 Cr | 2 | View details | |
| Ajanta Pharma Limited Listed CIN L24230MH1979PLC022059 | Active | 31 Dec 1979 | Mumbai, Maharashtra | ₹5,625 Cr | 7,869 | 10 | View details |
Board of directors of Resinno Biotech Private Limited (Resinno)
Resinno Biotech Private Limited is the primary company behind Resinno. The boards of the 2 registered companies of Resinno currently have 10 directors; the longest-serving is Madhusudan Bhagwandas Agrawal, appointed in 1979. 27 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhusudan Bhagwandas Agrawal DIN 00073872 | Whole-time director | 31 Dec 1979 | 46 yrs 9 mo | Ajanta Pharma Limited |
| Mannalal Bhagwandas Agrawal DIN 00073828 | Director | 31 Dec 1979 | 46 yrs 9 mo | Ajanta Pharma Limited |
| Yogesh Mannalal Agrawal DIN 00073673 | Managing Director | 01 Apr 2008 | 18 yrs 6 mo | Ajanta Pharma Limited |
| Rajesh Mannalal Agrawal DIN 00302467 | Whole-time director | 30 Apr 2013 | 13 yrs 5 mo | Ajanta Pharma Limited |
| Kafil Ahmed DIN 08020130 | Managing Director | 25 Jan 2018 | 8 yrs 9 mo | Resinno Biotech Private Limited |
| Vyankatesh Jethmal Pidiyar DIN 06836568 | Director | 28 Apr 2023 | 3 yrs 6 mo | Resinno Biotech Private Limited |
| David Paul Rasquinha DIN 01172654 | Director | 02 May 2024 | 2 yrs 5 mo | Ajanta Pharma Limited |
| Medha Vinay Joshi DIN 00328174 | Director | 02 May 2024 | 2 yrs 5 mo | Ajanta Pharma Limited |
| Simi Manohar Lal Thapar DIN 10470498 | Director | 02 May 2024 | 2 yrs 5 mo | Ajanta Pharma Limited |
| Rajesh Shashikant Dalal DIN 03504969 | Director | 02 May 2024 | 2 yrs 5 mo | Ajanta Pharma Limited |
Financials of Resinno
Figures of Resinno Biotech Private Limited, the primary company behind Resinno, for FY 2024. Revenue was ₹45.1 Lakh (-55% year on year). Net loss was -₹7.7 Lakh (-17% margin). EBITDA was -₹6.9 Lakh (-15% margin). Revenue has grown at a compounded annual rate of -9% over three years and +20% over five years.
- ₹45.1 LakhRevenue · FY 2024 · -55% YoY
- -₹7.7 LakhNet loss · -17% margin
- -₹6.9 LakhEBITDA · -15% margin
- ₹1.10 CrPaid-up capital
- -9%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Resinno Biotech Private Limited are on its company page.
Detailed financial statements for Resinno
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Resinno
Resinno has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Resinno
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Resinno
Resinno was founded in 2018.
Resinno is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Resinno, Resinno Biotech Private Limited, reported revenue of ₹45.1 Lakh for FY 2024, down 55% year on year.
Resinno serves as a cdmo specializing in the manufacturing of active pharmaceutical ingredients, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Resinno's top competitors include Laurus Labs, Symbiotec and SeQuent.
Resinno is associated with 2 legal entities: Resinno Biotech Private Limited, Ajanta Pharma Limited.
The legal entities of Resinno currently have 12 directors, including Arvind Kanhaiyalal Agrawal, Madhusudan Bhagwandas Agrawal, Rajesh Mannalal Agrawal and others.